MedPath

TO compare and evaluate the effects of Photodynamic therapy with conventional scaling and root planing at different intervals in chronic periodontitis patient: A Clinico-microbiological study

Phase 4
Completed
Conditions
Chronic periodontitis,
Registration Number
CTRI/2022/09/045334
Lead Sponsor
KVG DENTAL COLLEGE AND HOSPITAL
Brief Summary

This study is a randomized, double blinded, single center trial comparing and evaluating the clinical and microbial effects of photodynamic therapy using low level laser of 660nm wavelength and 0.1 mg/ml of Toluidine blue O dye irrigated for 60 seconds. Low level laser exposure done for 1 minute using swiping motion from apical to coronal direction within the periodontal pocket on the assigned treatment side. Each quadrant will be receiving scaling and root planing. one of the quadrant will receive one time exposure of Photodynamic therapy, other quadrant will be receiving two time exposure of Photodynamic therapy, In the remaining two quadrant one side will be receiving scaling and root planning treatment along with irrigation of 0.1 mg/ml of toluidine blue O dye while the other will be receiving scaling and root planing. Primary outcome is by assessing the clinical parameters such as gingival index, bleeding index, plaque index, periodontal probing depth and clinical attachment level which will be recorded during each appointments. Secondary outcome is by assessing the microbiological analysis by counting the colony forming units based on the samples drawn after each appointments.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
15
Inclusion Criteria
  • Systemically healthy patient.
  • chronic periodontitis patient with >5mm of periodontal probing depth present in each quadrant.
Exclusion Criteria
  • Patients with known systemic diseases.
  • Allergic to toluidine blue.
  • Patient who underwent treatment with antibiotics within the last six months.
  • Patient who underwent treatment with anti-inflammatory drug within the last three months.
  • Patient undergoing orthodontic treatment.
  • Patient who underwent periodontal therapy within the last six months.
  • Pregnancy or use of oral contraceptive.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To assess the reduction of periodontal probing depthbaseline | 6 week | 12 week
Secondary Outcome Measures
NameTimeMethod
to assess the microbial count in the samples collected after treatmentbaseline

Trial Locations

Locations (1)

KVG dental college and hospital

🇮🇳

Kannada, KARNATAKA, India

KVG dental college and hospital
🇮🇳Kannada, KARNATAKA, India
Dr Apoorva G
Principal investigator
8792246513
dr.apoorva135@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.